Meet the Current Researchers

Gheath Alatrash, D.O., Ph.D.

University of Texas M.D. Anderson Cancer Center

Can CAR-T Cell Therapy Be Used to Treat Lung Cancer?

Mehdi Alilou, Ph.D.

Case Western Reserve University

Novel Nodule Vessel Features to Predict Response to Lung Cancer Therapies

Christina Barkauskas, M.D.

Duke University

Testing Tapeworm Drug Against COVID-19 Virus

R. Graham Barr, M.D., Dr.PH

The Trustees of Columbia University in NYC

The Collaborative Cohort of Cohorts for COVID-19 Research (C4R) CT Study

Tishra Beeson, DrPH, MPH

Central Washington University (CWU)

Keys to Prevention: Reducing Community Spread of COVID-19 in Vulnerable Communities

Alfonso Bellacosa, M.D., M.H.S.

Fox Chase Cancer Center

Improving Response Rates of Immunotherapy for Lung Cancer

Georgiana Bostean, Ph.D.

Chapman University

Leveraging policy and retail environments to reduce adolescent vaping and smoking of tobacco and cannabis products

Meredith Brooks, Ph.D.

Harvard Medical School

Geospatial signals in pediatric tuberculosis

Nunzia Caporarello, Ph.D.

Mayo Clinic

Targeting vascular rarefaction and loss of endothelial identity in pulmonary fibrosis

Juan Carlos Cardet, M.D.

University of South Florida

Looking for Genetic Markers for Severe Asthma

Francisco Cartujano, M.D.

University of Rochester

Using Text Messaging to Stop Vaping

Stephen Chan, M.D., Ph.D.

University of Pittsburgh

NCOA7 as a novel therapeutic and genetic diagnostic target in SARS-CoV-2 infection

Ya-Wen Chen, Ph.D.

University of Southern California

Roles of hypoxia and Wnt signaling in human progenitor cell fate decision during lung injury

Haiying Cheng, M.D, Ph.D.

Albert Einstein College of Medicine

Potential new immune evasion pathways and molecular targets in lung cancer

Sangwoon Chung, Ph.D.

The Ohio State University

Preventing neutrophilic inflammation in severe asthma by targeting ETosis

Sarah Clark, Ph.D.

University of Colorado

Using Probiotics to Improve Pneumonia Treatment  

Bria Coates, M.D. 

Ann & Robert H. Lurie Children's Hospital of Chicago 

Why Does SARS-CoV-2 Rarely Cause Severe Disease in Children?

Miranda Curtiss, M.D., Ph.D.

University of Alabama at Birmingham

CXCR5/Chi3l1 axis regulates allergic disease

Suellen D`Arc dos Santos Oliveira, Ph.D

University of Illinois at Chicago

Role of Caveolin-1 and BMPRII Short Form in Pulmonary Vascular Homeostasis

Brandon DeKosky, Ph.D.

University of Kansas Center for Research, Inc.

Molecular analysis of antibody responses associated with COVID-19 respiratory distress

Andrew Dylag, M.D.

University of Rochester Medical Center

Airway Disease Due to Aberrant Matrix Remodeling After Neonatal Hyperoxia

Hyungjin Eoh, D.V.M., Ph.D

University of Southern California

Drug resistance of Mycobacterium tuberculosis is enhanced by the trehalose metabolism remodeling

Sean Fain, Ph.D.

University of Iowa

Understanding “Long Haul” COVID-19

Sean M. Frey, M.D.

University of Rochester

Providing Asthma Education to Children in the Hospital and at Home

Marta Maria Gaglia, Ph.D.

Trustees of Tufts College (Tufts University)

Control of innate immune responses by SARS-CoV-2

Marcia Goldberg, M.D.

Massachusetts General Hospital (The General Hospital Corp.)

High resolution definition of the pathogenic immune response in ARDS during COVID-19 infection

Ana Patricia da Silva Gomes, Ph.D.

H. Lee Moffitt Cancer Center

Understanding the Effect of the Aging Process on Lung Cancer Treatment

Gregory Gray, M.D., M.P.H.

University of Texas Medical Branch

Studying First Canine-Like Coronavirus Associated with Disease in Humans

Philip Greenberg, M.D.

Fred Hutchinson Cancer Research Center

Overcoming obstacles for cellular immunotherapy against lung cancer

Duc  M. Ha, M.D., M.A.S.

Kaiser Permanente Colorado Institute for Health Research

Overcoming Breathlessness in Lung Cancer Survivors